Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

16.70
Delayed Data
As of Jun 23
 +0.20 / +1.21%
Today’s Change
7.75
Today|||52-Week Range
32.20
+26.04%
Year-to-Date
Adamis Gets FDA Nod for Generic Version of Mylan's EpiPen
Jun 16 / Zacks.com - Paid Partner Content
Why Is Impax (IPXL) Down 2.4% Since the Last Earnings Report?
Jun 14 / Zacks.com - Paid Partner Content